Riskpilot← Back to searchSign inGet full accessSKANSEN LEGEKONTOR AS
ASActiveOrg 912715515Skippergata 7, 9008 TromsøGeneral medical practice activities · NACE 8621Est. 201318 employees
Revenue 2024
NOK 6,6M
+20% vs 2023
EBITDA margin
5.2%
+75% vs 2023
Equity ratio
-17.7%
Financial strength
Net profit 2024
NOK 317K
+62% vs 2023
| Revenue | NOK 6,6M | +20% |
| EBITDA | NOK 346K | +75% |
| Net profit | NOK 317K | +62% |
| Total assets | NOK 508K | +89% |
| Equity | NOK -90K | +78% |
| Employees | 18 | — |
Legal name
SKANSEN LEGEKONTOR AS
Org number
912715515
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
11. november 2013
Share capital
NOK 36 000
Employees
18 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Signatur av styrets leder og styrets nestleder i fellesskap
Company purpose
Helsetjenester og det som står i naturlig forbindelse med dette.
Address
Skippergata 7, 9008 Tromsø
Phone
+4777601717
Email
postmottak@skansen.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 459 | 5 430 | 5 949 | 5 532 | 6 615 |
| Staff expenses | −2 041 | −2 090 | −2 708 | −2 188 | −3 027 |
| EBITDA | 259 | 151 | −254 | 197 | 346 |
| Depreciation & amort. | −255 | −138 | −0 | −0 | −0 |
| EBIT | 4 | 14 | −254 | 197 | 346 |
| Net financials | 61 | 60 | 48 | −1 | −1 |
| Profit before tax | 65 | 73 | −206 | 196 | 345 |
| Tax | −0 | −0 | −0 | −0 | 28 |
| Net profit | 65 | 73 | −206 | 196 | 317 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 495 | 474 | 457 | 269 | 508 |
| Equity | −469 | −396 | −602 | −407 | −90 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 964 | 870 | 1 059 | 676 | 598 |
| Total debt | 964 | 870 | 1 059 | 676 | 598 |
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
20202024
Equity ratio
-17.7%
This company
38.2%
Market median
-146% vs market
20202024
Return on equity
31683700.0%
This company
18.4%
Market median
+172193922% vs market
20202024
Net profit margin
4.8%
This company
8.1%
Market median
-41% vs market
20202024
Asset turnover
13.02×
This company
1.12×
Market median
+1062% vs market
20202024
Debt / equity
6.66×
This company
0.62×
Market median
-974% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SKANSEN LEGEKONTOR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elisabeth Louise Møller | Board of Directors | 0 companies |